global medical writing & transparency
Your strategic partner for the preparation of regulatory documents.

Navigate the ever-evolving regulatory landscape with a flexible and agile team of trusted experts
Our distinct approach enables us to provide exceptional, tailored support for your medical writing and clinical trial disclosure needs, whether through standalone projects, comprehensive trial assistance, or dedicated FSP resourcing.
Medical Writing and Clinical Trials Disclosure
We are knowledgeable and solutions-oriented subject matter experts with deep domain expertise who focus on every detail to deliver a superior client experience.

Global Medical Writing and Transparency
Medical Writing
ProPharma's medical writers provide strategic, responsive, and flexible medical writing project support. Our team of experts autonomously drive document development, assimilating and summarizing complex scientific data into concise, accurate reports for a wide variety of audiences.
Whether you need project-based support for individual medical writing deliverables or to outsource all medical writing across an entire clinical trial or a complete portfolio of products, our expertise and experience can be leveraged to ensure all your project goals are achieved.
Quality Control Review
Detailed, thorough quality control (QC) reviews are an integral part of the production lifecycle of a document. ProPharma's QC experts review documents across all therapeutic areas to ensure message uniformity, data integrity, and consistency.
Clinical Trials Disclosure Services
ProPharma partners with clients to provide individualized, single-source, scalable solutions within the clinical trials disclosure and transparency landscape.
Thousands of Records Posted, >90% without NIH Comments
Finding experienced resources to register and report your clinical trial, provide document redaction services, or locating the right team for end-to-end management and support of an entire portfolio of studies can be difficult.
Our Clinical Trials Disclosure (CTD) experts are here for you.
Our dedicated team of disclosure experts have successfully registered thousands of studies across multiple registries/therapeutic areas and reviewed thousands of pages for personal and commercially confidential information for redaction.
Let our seasoned project managers and authors navigate you through the ever-evolving clinical trials disclosure landscape.
Medical Writing & Clinical Trials Disclosure Experts
-
Meg Weber
Vice President, Medical Writing
-
Carrie Yazell
Director, Medical Writing and Quality Control
-
Cynthia Fuller
Senior Director, Medical Writing
-
Pinky Sharma
Director, Medical Writing
-
Janice Worley
Vice President, Medical Writing
-
Meg Weber
Vice President, Medical Writing
-
Carrie Yazell
Director, Medical Writing and Quality Control
-
Cynthia Fuller
Senior Director, Medical Writing
-
Pinky Sharma
Director, Medical Writing
-
Janice Worley
Vice President, Medical Writing
-
Meg Weber
Vice President, Medical Writing
-
Carrie Yazell
Director, Medical Writing and Quality Control
-
Cynthia Fuller
Senior Director, Medical Writing
-
Pinky Sharma
Director, Medical Writing
-
Janice Worley
Vice President, Medical Writing
-
Meg Weber
Vice President, Medical Writing
-
Carrie Yazell
Director, Medical Writing and Quality Control
-
Cynthia Fuller
Senior Director, Medical Writing
-
Pinky Sharma
Director, Medical Writing
-
Janice Worley
Vice President, Medical Writing
-
Meg Weber
Vice President, Medical Writing
Pinky Sharma
Janice Worley
Meg Weber
Carrie Yazell
Cynthia Fuller

Meeting Complex Needs with Strategic Support
ProPharma provides adaptable and targeted assistance designed to align with your specific requirements. Our approach ensures effective outcomes tailored to your scope and scale.
News & Insights

March 18, 2025
FAQs: Model Informed Drug Development (MIDD) & Modeling and Simulation (M&S)
Discover how Model-Informed Drug Development (MIDD) and Modeling & Simulation (M&S) optimize clinical trials, enhance drug dosing, and streamline FDA approvals.

March 13, 2025
Navigating the New EU Health Technology Assessment Regulation (HTAR): Are You Ready?
New EU Health Technology Assessment Regulation (HTAR) is here. Learn how Joint Clinical Assessments (JCA) and Joint Scientific Consultations (JSC) impact market authorization and what health...

January 31, 2025
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

October 21, 2024
ProPharma Appoints Brian Tuttle as Chief Financial Officer
ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

January 31, 2025
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

October 9, 2024
ProPharma Receives 2024 CPHI Regulatory and Compliance Award
ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

June 10, 2022
The Cost of Poor Project Management
Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

August 31, 2022
Successfully Passing MHRA Inspections for Overseas Manufacturing Sites
ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...
News & Insights